 |
 |

Livedo Reticularis Associated With Increased Titers of Anticardiolipin Antibodies in Systemic Lupus Erythematosus
Cynthia Weinstein, MBBS, FACD, FRACP;
Marian H. Miller, MBBS, FRACP;
Rani Axtens;
Russell Buchanan, MBBS, FRACP;
Geoffrey O. Littlejohn, MBBS, FRACP
Arch Dermatol. 1987;123(5):596-600.
Abstract
 |  |
Seventy-eight consecutive patients with systemic lupus erythematosus were assessed for the presence of livedo reticularis. The possible association of livedo reticularis with other clinical and laboratory features including anticardiolipin antibodies was explored. Thirty-eight patients had livedo reticularis. Four cases were severe, 11 moderate, and 23 mild. There was a statistically significant association between the combined moderate and severe livedo reticularis group and elevated levels of anticardiolipin antibodies. The recognized association of anticardiolipin antibodies with thrombotic events suggests a possible pathogenetic role. The presence or history of central nervous system disease, renal disease, vasculitis, or lupus inhibitor was significantly associated with the moderate and severe livedo reticularis group. Livedo reticularis may be a cutaneous marker for the later development of important systemic events in systemic lupus erythematosus.
(Arch Dermatol 1987;123:596-600)
Author Affiliations
From the Departments of Dermatology (Dr Weinstein), Rheumatology (Dr Miller), and Medicine (Dr Littlejohn), Prince Henry's Hospital, Department of Medicine, Austin Hospital (Dr Buchanan), and Department of Medicine, Monash University (Dr Littlejohn), Melbourne, Australia. Mr Axtens is a medical student at Monash University, Alfred Medical School, Melbourne.
Footnotes
Accepted for publication Oct 31, 1986.
Reprint requests to Medical Suite 10, St Andrew's Hospital, 12 St Andrew's PI, East Melbourne, 3002 Victoria, Australia 3002 (Dr Weinstein).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Clinical Importance of Positive Test Results for Lupus Anticoagulant and Anticardiolipin Antibodies
Proven et al.
Mayo Clin Proc. 2004;79:467-475.
ABSTRACT
Erythema nodosum associated with antiphospholipid antibodies: a report of three cases
Nekhlyudov et al.
Lupus 2000;9:641-645.
ABSTRACT
Syndromes of Thrombosis and Hypercoagulability: Congenital and Acquired Thrombophilias
Bick and Kaplan
CLIN APPL THROMB HEMOST 1998;4:25-50.
ABSTRACT
The Antiphospholipid Thrombosis Syndromes: A Common Multidisciplinary Medical Problem
Bick
CLIN APPL THROMB HEMOST 1997;3:270-283.
ABSTRACT
Cutaneous manifestations of Hughes syndrome occurring in the context of lupus erythematosus
Frances and Piette
Lupus 1997;6:139-144.
Clinical manifestations and management of the antiphospholipid syndrome
Derksen
Lupus 1996;5:167-169.
ABSTRACT
Anticardiolipin Antibodies in Acquired Immunodeficiency Syndrome
Stimmler et al.
Arch Intern Med 1989;149:1833-1835.
ABSTRACT
The Anticardiolipin Syndrome: A New Way to Slice an Old Pie, or a New Pie to Slice?
Sontheimer
Arch Dermatol 1987;123:590-595.
ABSTRACT
|